Clinical Trials Sponsored by Cempra Pharmaceuticals
Total 19828 results
-
Bellicum PharmaceuticalsCompletedCastrate Resistent Prostate CancerUnited States
-
Alexion PharmaceuticalsTerminatedMyasthenia GravisUnited States, Canada, United Kingdom
-
Aerie PharmaceuticalsCompletedPrimary Open Angle Glaucoma or Ocular HypertensionUnited States
-
Endo PharmaceuticalsCompletedEdematous Fibrosclerotic PanniculopathyUnited States
-
Ferring PharmaceuticalsTerminated
-
Ferring PharmaceuticalsCompleted
-
Alexion PharmaceuticalsTerminatedNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderHong Kong, United States, United Kingdom, Croatia, Malaysia, Korea, Republic of, Turkey, Japan, Italy, Spain, Taiwan, Australia, Argentina, Thailand, Russian Federation, Czechia, Denmark, Germany
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom, Netherlands, Ireland, Greece, France, Belgium, Denmark, Norway, Italy, Slovakia, Switzerland, Portugal, Finland, Hungary, Germany
-
Jazz PharmaceuticalsCompletedObstructive Sleep Apnea | NarcolepsyUnited States, France, Canada, Germany, Netherlands, Finland
-
Regeneron PharmaceuticalsCompleted
-
Concert PharmaceuticalsCompleted
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open Angle GlaucomaUnited States
-
Regeneron PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Alexion PharmaceuticalsCompletedStage V Chronic Kidney DiseaseAustralia, France, Italy, Spain, United Kingdom, Sweden
-
Regeneron PharmaceuticalsWithdrawnSporadic Inclusion Body Myositis
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Canada
-
Alexion PharmaceuticalsApproved for marketingHypophosphatasiaUnited States, France
-
Alnylam PharmaceuticalsCompletedATTR Amyloidosis | Transthyretin (TTR)-Mediated Amyloidosis | Familial Amyloidotic Polyneuropathy (FAP) | Familial Amyloid NeuropathiesFrance, Germany, Portugal, United Kingdom, Sweden, Spain
-
Impel PharmaceuticalsCompletedMigraine HeadacheAustralia
-
Alexion PharmaceuticalsCompletedHypophosphatasia | Bone DiseaseUnited States
-
Alexion PharmaceuticalsCompletedHypophosphatasiaUnited States, Spain, Australia, United Kingdom, Italy, France, Canada, Germany, Japan, Russian Federation, Saudi Arabia, Turkey
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompleted
-
Lexicon PharmaceuticalsCompletedHealthy | Renal ImpairmentUnited States
-
Vanda PharmaceuticalsUnknownRelapsed or Refractory Hematologic MalignanciesUnited States
-
Prolong PharmaceuticalsTerminatedChemotherapy-induced NeutropeniaFrance, Netherlands
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraUnited States, Australia, United Kingdom, Canada, Italy, Denmark, Hungary, Netherlands
-
Cumberland PharmaceuticalsCompleted
-
Cumberland PharmaceuticalsCompletedStaphylococcal Skin InfectionUnited States
-
Cumberland PharmaceuticalsCompletedBacterial PneumoniaUnited States
-
Cumberland PharmaceuticalsCompletedKidney Diseases | End Stage Renal DiseaseUnited States
-
Cumberland PharmaceuticalsCompletedComplicated Skin and Skin Structure Infections | Hospital Acquired Bacterial Pneumonia | Ventilator Associated Bacterial Pneumonia | Gram Positive InfectionUnited States
-
Titan PharmaceuticalsCompleted
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Titan PharmaceuticalsTerminatedOpioid DependenceUnited States
-
Lexicon PharmaceuticalsCompleted
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD) | LAL-DeficiencyFrance, United States, United Kingdom, Czechia
-
X4 PharmaceuticalsWithdrawn
-
Ferring PharmaceuticalsCompleted
-
Xeris PharmaceuticalsCompletedHypoglycemia | Diabetes Mellitus, Type 1United States, Canada
-
ASLAN PharmaceuticalsCompletedSolid TumorTaiwan, Hong Kong
-
Impel PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsWithdrawnAtypical Hemolytic Uremic SyndromeSweden, Moldova, Republic of, Latvia, Lithuania, Estonia, Bosnia and Herzegovina, Canada, Georgia, Macedonia, The Former Yugoslav Republic of, Serbia
-
Alnylam PharmaceuticalsCompletedTransthyretin-mediated Amyloidosis (ATTR Amyloidosis)United Kingdom
-
Ferring PharmaceuticalsCompleted
-
Ferring PharmaceuticalsCompletedOveractive BladderUnited States
-
ASLAN PharmaceuticalsCompletedHealthy VolunteersUnited Kingdom